counter statistics
Health News

FDA Authorizes COVID Amplifiers for All American Adults


19 Nov. 2021 – The FDA gives the green light for third, or booster doses of Pfizer and Moderna vaccines for all over 18, before the busy winter holiday season.

“… Authorization of the use of a single booster dose of either the Moderna or the Pfizer-BioNTech COVID-19 vaccine for individuals 18 years of age and older helps to provide sustained protection against COVID-19, including the severe consequences that can occur, such as hospitalization and death, ”Janet Woodcock, MD, acting FDA commissioner, said in an FDA press release.

The CDC’s Advisory Committee on Immunization Practices, or ACIP, will meet this afternoon to review the science that supports a more widespread need for booster doses, and is expected to vote on official recommendations for its use in the US. The CDC director must then sign off on the panel’s recommendations.

“Once the FDA reviews this data and provides an authorization, we will act quickly at CDC,” Walensky said during a recent White House briefing.

Several states – including Louisiana, Maine and Colorado – have already authorized boosters for all adults as cases increase in Europe and across the western and northeastern regions of the United States.

FDA officials said they hoped greater suitability for boosters would reduce the confusion for people and hopefully speed up the recording of the shots.

“Streamlining the eligibility criteria and making booster doses available to all individuals 18 years and older will also help eliminate confusion about who can receive a booster dose and ensure that booster doses are available to anyone who may need one,” he said. Peter Marks said. MD, PhD, who heads the FDA’s Center for Biological Evaluation and Research.

“… Authorization of the use of a single booster dose of either the Moderna or the Pfizer-BioNTech COVID-19 vaccine for individuals 18 years of age and older helps to provide sustained protection against COVID-19, including the severe consequences that can occur, such as hospitalization and death, ”said Janet Woodcock, MD, acting FDA commissioner



Source link

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button